Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
2018 · Cell · 590 citations
https://doi.org/10.1016/j.cell.2018.04.034
L
Lisha Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1.3K
Citations
11
h-index
11
i10-index
Lisha Wang is an academic researcher from Army Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Immune Cell Function and Interaction. The author has an h-index of 11, co-authored 23 publications.
ORCID: 0000-0002-1828-8343Papers by this author
worksThe dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
2021 · Signal Transduction and Targeted Therapy · 39 citations
https://doi.org/10.1038/s41392-021-00525-3
Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
2020 · Frontiers in Immunology · 33 citations
https://doi.org/10.3389/fimmu.2020.00806
Apoptosis dysfunction: unravelling the interplay between ZBP1 activation and viral invasion in innate immune responses
2024 · Cell Communication and Signaling · 19 citations
https://doi.org/10.1186/s12964-024-01531-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat